「stg.senju」の検索結果
507件：391～395件目を表示
もしかして
-
December 22, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
December 22, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
January 17, 2025 General Announcement: Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Senju has Applied for Manufacturing and Marketing Approval in Japan for the novel Dry Eye Disease
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf -
临床试验信息 | 研究与开发 | 千寿制药株式会社
List of Clinical Trial Summaries ※Listed in order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Jap
http://www.senju.co.jp/chinese/rd/trial.html -
お知らせ | 千寿製薬株式会社
June 1, 2026 Launch of Distribution of 3in1Smart and SPM-700（PDF） April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（
https://www.senju.co.jp/english/news/